Signaling mechanisms involved in the regulation of remyelination in multiple sclerosis: a mini review

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Journal of molecular medicine

• Publication date

  2023-04-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00109-023-02312-9PMID 37084092
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of Tau in Various Tauopathies, Treatment Approaches, and Emerging Role of Nanotechnology in Neurodegenerative Disorders

  2022cited by this paper
• Retinoid X Receptor: Cellular and Biochemical Roles of Nuclear Receptor with a Focus on Neuropathological Involvement

  2022cited by this paper
• Effect of Dual-Task Motor-Cognitive Training in Preventing Falls in Vulnerable Elderly Cerebrovascular Patients: A Pilot Study

  2022cited by this paper
• Oligodendrocyte Development and Regenerative Therapeutics in Multiple Sclerosis

  2021cited by this paper
• Biological Significance of NOTCH Signaling Strength

  2021cited by this paper
• The MS Remyelinating Drug Bexarotene (an RXR Agonist) Promotes Induction of Human Tregs and Suppresses Th17 Differentiation In Vitro

  2021cited by this paper
• O-GlcNAcylation in Ventral Tegmental Area Dopaminergic Neurons Regulates Motor Learning and the Response to Natural Reward

  2021cited by this paper
• Exploiting the preferential phagocytic uptake of nanoparticle-antigen conjugates for the effective treatment of autoimmunity.

  2021cited by this paper
• Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study.

  2021cited by this paper
• Pinocembrin Promotes OPC Differentiation and Remyelination via the mTOR Signaling Pathway

  2021cited by this paper
• Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition

  2020cited by this paper
• The mechanistic target of rapamycin pathway downregulates bone morphogenetic protein signaling to promote oligodendrocyte differentiation

  2020cited by this paper
• Functional activity of anti-LINGO-1 antibody opicinumab requires target engagement at a secondary binding site

  2020cited by this paper
• Targeting Keap1/Nrf2/ARE signaling pathway in multiple sclerosis.

  2020cited by this paper
• Substrate Specific Inhibitor Designed against the Immunomodulator GMF-beta Reversed the Experimental Autoimmune Encephalomyelitis

  2020cited by this paper
• Opicinumab: is it a potential treatment for multiple sclerosis?

  2020cited by this paper
• Novel Treatment Strategies Targeting Myelin and Oligodendrocyte Dysfunction in Schizophrenia

  2020cited by this paper
• Molecular Interventions towards Multiple Sclerosis Treatment

  2020cited by this paper
• An Overview of Nrf2 Signaling Pathway and Its Role in Inflammation

  2020cited by this paper
• Treatment of Multiple Sclerosis: A Review.

  2020cited by this paper
• LINGO-1 deficiency promotes nerve regeneration through reduction of cell apoptosis, inflammation, and glial scar after spinal cord injury in mice.

  2019cited by this paper
• Roles of mTOR Signaling in Tissue Regeneration

  2019cited by this paper
• The Notch pathway in CNS homeostasis and neurodegeneration

  2019cited by this paper
• Ginkgolide K supports remyelination via induction of astrocytic IGF/PI3K/Nrf2 axis.

  2019cited by this paper
• Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development

  2019influential reference
• An unmet clinical need: roads to remyelination in MS

  2019cited by this paper
• Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial.

  2019cited by this paper
• Promoting remyelination in multiple sclerosis

  2019cited by this paper
• The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis

  2018cited by this paper
• Interactions Between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma on Neuroinflammation, Demyelination, and Remyelination in Multiple Sclerosis

  2018cited by this paper
• Disease-modifying therapies for multiple sclerosis

  2018cited by this paper
• Mechanisms and Medicines for Remyelination.

  2017cited by this paper
• Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis

  2017cited by this paper
• Nrf2 signaling pathway: Pivotal roles in inflammation.

  2017influential reference
• LINGO-1 and AMIGO3, potential therapeutic targets for neurological and dysmyelinating disorders?

  2017cited by this paper
• Anti lingo 1 (opicinumab) a new monoclonal antibody tested in relapsing remitting multiple sclerosis

  2017cited by this paper
• Drug discovery for remyelination and treatment of MS

  2017influential reference
• Remyelination therapies: a new direction and challenge in multiple sclerosis

  2017cited by this paper
• Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet.

  2017cited by this paper
• Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies

  2017cited by this paper
• Intracellular signaling pathway regulation of myelination and remyelination in the CNS.

  2016cited by this paper
• Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis.

  2016cited by this paper
• Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelination.

  2015cited by this paper
• Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis

  2015cited by this paper
• A decade from discovery to therapy: Lingo-1, the dark horse in neurological and psychiatric disorders.

  2015cited by this paper
• Targeting the cis‐dimerization of LINGO‐1 with low MW compounds affects its downstream signalling

  2015cited by this paper
• [Disease modifying therapies in multiple sclerosis].

  2014cited by this paper
• Disease Modifying Therapy in Multiple Sclerosis

  2014cited by this paper
• The notch signaling pathway: its role in focal CNS demyelination and apotransferrin‐induced remyelination

  2013cited by this paper
• Myelin Recovery in Multiple Sclerosis: The Challenge of Remyelination

  2013cited by this paper
• Wnt Signaling in Remyelination in Multiple Sclerosis: Friend or Foe?

  2013cited by this paper
• Notch signaling in the pathologic adult brain

  2013cited by this paper
• Promoting Remyelination in Multiple Sclerosis—Recent Advances

  2013cited by this paper
• Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis.

  2013cited by this paper
• Notch Signaling and T-Helper Cells in EAE/MS

  2013cited by this paper
• Wnt Signaling in the Pathogenesis of Multiple Sclerosis-Associated Chronic Pain

  2012cited by this paper
• Multiple sclerosis - remyelination failure as a cause of disease progression.

  2012cited by this paper
• Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination

  2011cited by this paper
• Notch Signaling Regulates Mouse and Human Th17 Differentiation

  2011cited by this paper
• Not(ch) just development: Notch signalling in the adult brain

  2011cited by this paper
• Myelin Regeneration in Multiple Sclerosis: Targeting Endogenous Stem Cells

  2011cited by this paper
• Regulation of remyelination in multiple sclerosis

  2011influential reference
• Overcoming remyelination failure in multiple sclerosis and other myelin disorders.

  2010cited by this paper
• Notch: a new player in MS mechanisms.

  2010cited by this paper
• Rheb G-Proteins and the Activation of mTORC1.

  2010cited by this paper
• Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions.

  2010cited by this paper
• Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS.

  2009cited by this paper
• The canonical Notch signaling pathway: unfolding the activation mechanism.

  2009cited by this paper
• The AKT axis as a therapeutic target in autoimmune diseases.

  2009cited by this paper
• News & Analysis

  2009cited by this paper
• Wnt/beta-catenin signaling: components, mechanisms, and diseases.

  2009cited by this paper
• LINGO-1 and its role in CNS repair.

  2008cited by this paper
• The many facets of Notch ligands

  2008cited by this paper
• LINGO-1 antagonists as therapy for multiple sclerosis: in vitro and in vivo evidence

  2008cited by this paper
• Notch signaling in normal and disease States: possible therapies related to glycosylation.

  2007cited by this paper
• Notch signalling during peripheral T-cell activation and differentiation

  2007cited by this paper
• Inhibition of Notch signaling enhances tissue repair in an animal model of multiple sclerosis.

  2005cited by this paper
• Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis

  2004cited by this paper
• Minireview Wnt Pathway Activation: New Relations and Locations

  year unknowncited by this paper

• A Machine Learning Pipeline for Multiple Sclerosis Biomarker Discovery: Comparing explainable AI and Traditional Statistical Approaches

  2025cites this paper
• Low-Intensity Pulsed Ultrasound Promotes Oligodendrocyte Maturation and Remyelination by Down-regulating the Interleukin-17A/Notch1 Signaling Pathway in Mice with Ischemic Stroke

  2025cites this paper
• The role of notch signaling in regulating myeloid-derived suppressor cells: Implications in Cancer and autoimmune diseases.

  2025cites this paper
• Decoding the regulatory network of microRNAs, lncRNAs, and transcription factors in relapsing-remitting multiple sclerosis: A case-control in silico study

  2025cites this paper
• The mechanism of exosomes of BMSCs modified with Bu Shen Yi Sui capsule in promoting remyelination via regulating miR-15b/Wnt signaling pathway-mediated differentiation of oligodendrocytes.

  2024cites this paper
• Exploring the immune‐modulating properties of boswellic acid in experimental autoimmune encephalomyelitis

  2024cites this paper
• Genetic Contribution to Medium-Term Disease Activity in Multiple Sclerosis

  2024cites this paper
• Notch Signaling in Central Nervous System: From Cellular Development to Multiple Sclerosis Disease

  2024cites this paper
• Chelation Therapy Associated with Antioxidant Supplementation Can Decrease Oxidative Stress and Inflammation in Multiple Sclerosis: Preliminary Results

  2023cites this paper